Cargando…
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity
Autores principales: | Richeldi, Luca, Cottin, Vincent, Brown, Kevin K., Flaherty, Kevin R., Johannson, Kerri A., Travis, William D., Collard, Harold R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812455/ https://www.ncbi.nlm.nih.gov/pubmed/31442070 http://dx.doi.org/10.1164/rccm.201905-0932LE |
Ejemplares similares
-
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
por: Cottin, Vincent, et al.
Publicado: (2022) -
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
por: Flaherty, Kevin R, et al.
Publicado: (2017) -
Variability in Global Prevalence of Interstitial Lung Disease
por: Kaul, Bhavika, et al.
Publicado: (2021) -
Reply to Watanabe et al.: Pleuroparenchymal Fibroelastosis Induced by Liver Transplantation?
por: Goondi, Damanjit, et al.
Publicado: (2021) -
Models of disease behavior in idiopathic pulmonary fibrosis
por: Johannson, Kerri A., et al.
Publicado: (2015)